These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 17301120

  • 1. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Yokoi M, Yamagishi S, Saito A, Yoshida Y, Matsui T, Saito W, Hirose S, Ohgami K, Kase M, Ohno S.
    Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
    [Abstract] [Full Text] [Related]

  • 2. Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy.
    Yoshida Y, Yamagishi S, Matsui T, Nakamura K, Imaizumi T, Yoshimura K, Yamakawa R.
    Br J Ophthalmol; 2007 Sep; 91(9):1133-4. PubMed ID: 17389742
    [Abstract] [Full Text] [Related]

  • 3. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 4. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ.
    Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
    [Abstract] [Full Text] [Related]

  • 5. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B, Li T, Chen H, Xu X, Zheng Z.
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [Abstract] [Full Text] [Related]

  • 6. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V.
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [Abstract] [Full Text] [Related]

  • 7. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N, Monickaraj F, Balasubramanyam M, Rema M, Mohan V.
    J Diabetes Complications; 2012 Jun; 26(5):435-41. PubMed ID: 22699109
    [Abstract] [Full Text] [Related]

  • 8. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA.
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 11. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH, Oh J, Roh JH, Huh K.
    Ophthalmologica; 2009 May; 223(3):188-91. PubMed ID: 19182495
    [Abstract] [Full Text] [Related]

  • 12. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 13. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC, La Heij EC, Diederen RM, Kessels AG, Liem AT, Kijlstra A, Hendrikse F.
    Ophthalmic Res; 2007 Mar; 39(3):148-54. PubMed ID: 17534114
    [Abstract] [Full Text] [Related]

  • 14. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.
    Ophthalmic Res; 2007 Mar; 39(2):92-7. PubMed ID: 17284935
    [Abstract] [Full Text] [Related]

  • 15. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X, Wang G, Wang Y.
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [Abstract] [Full Text] [Related]

  • 16. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M, Ogata N, Minamino K, Higuchi A, Matsumura M.
    Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
    [Abstract] [Full Text] [Related]

  • 17. Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis.
    Yoshida Y, Yamagishi S, Matsui T, Nakamura K, Imaizumi T, Yoshimura K, Yamakawa R.
    Br J Ophthalmol; 2007 Jun; 91(6):737-8. PubMed ID: 17166895
    [Abstract] [Full Text] [Related]

  • 18. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.
    Yokoi M, Yamagishi SI, Takeuchi M, Ohgami K, Okamoto T, Saito W, Muramatsu M, Imaizumi T, Ohno S.
    Br J Ophthalmol; 2005 Jun; 89(6):673-5. PubMed ID: 15923499
    [Abstract] [Full Text] [Related]

  • 19. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
    Chernykh VV, Varvarinsky EV, Smirnov EV, Chernykh DV, Trunov AN.
    Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060
    [Abstract] [Full Text] [Related]

  • 20. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.